Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pancreatic Neoplasms × Sugars × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 Leiomyoma 2 cyclopia sequence 1 Vomiting 1 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Pain 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Nausea 1 Myasthenia Gravis 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma 1 Lung Neoplasms 1 Lower Urinary Tract Symptoms 1 Insulin Resistance 1 Infertility 1 Hyperandrogenism 1 Hot Flashes 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Diarrhea 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 99 130-nm albumin-bound paclitaxel 34 Oxaliplatin 28 Capecitabine 27 Fluorouracil 25 Albumin-Bound Paclitaxel 23 Leucovorin 19 Irinotecan 18 Erlotinib Hydrochloride 14 Radiosurgery 11 Cyclophosphamide 11 pembrolizumab 10 Radiotherapy 10 Nivolumab 10 Bevacizumab 10 Surgical Procedures, Operative 9 avelumab 7 Docetaxel 7 Taxes 6 Cisplatin 6 ruxolitinib 5 folfirinox 5 Paclitaxel 5 Everolimus 5 Cetuximab 5 ALT-803 5 spartalizumab 4 Specimen Handling 4 S 1 (combination) 4 Radiotherapy, Intensity-Modulated 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02767752 2018-07-10

CHIPAC

Herlev Hospital

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡